Could I add on to that?
There were data also from the prototype vaccine in the younger age groups coming in as well.There were half doses there, so we did have an idea coming in for that. The reason we went forward so quickly was that we could see from this first dose that there was sufficient immunity to go on; otherwise, we would have had to wait until November to get the results of the final study.